Table 1 Patient and sample characteristics
Total number | Total number in ERG-negative | Total number in ERG-positive | |
|---|---|---|---|
Patients | 16 | 7 | 10 |
Benign samples | 59 | ||
Malignant samples | |||
all | 70 | 24 | 46 |
OCT embedded | 10 | 6 | 4 |
not-OCT embedded | 60 | 18 | 42 |
Percentage of epithelium | |||
1–25% | 24 | 6 | 18 |
26–50% | 39 | 15 | 24 |
51–75% | 6 | 3 | 3 |
> 75% | 1 | 0 | 1 |
Percentage of malignancy | |||
1–10% | 21 | 3 | 18 |
11–20% | 24 | 7 | 17 |
21–30% | 10 | 7 | 3 |
31–40% | 8 | 4 | 4 |
41–50% | 3 | 3 | 0 |
51–60% | 0 | 0 | 0 |
61–70% | 4 | 0 | 4 |
Percentage of malignancy to total epithelium area | |||
1–25% | 9 | 1 | 8 |
26–50% | 18 | 5 | 13 |
51–75% | 16 | 7 | 9 |
> 75% | 27 | 11 | 16 |
Gleason score | |||
3 + 3 | 43 | 7 | 36 |
3 + 4 | 16 | 10 | 6 |
4 + 3 | 10 | 6 | 4 |
4 + 4 | 1 | 1 | 0 |